WHO WE ARE
Viga Gemilang was formed in 2019, later incorporated as Viga Gemilang Diagnostics Sdn Bhd in Malaysia to develop and commercialize innovative Point of Care (POC) tests for tropical infectious diseases important to Malaysia and Asia. Viga Gemilang’s mission is to develop POC diagnostic solutions in areas with high unmet needs globally.
Our new product focus is to develop a point of care test for COVID-19 locally and develop a local manufacturing site for both infectious and non-infectious diseases. We believe this is important to not only build a company of value by providing more products but it also serves the population of Malaysia for quality of care.
Such diseases in our consideration include Tuberculosis, Typhoid, cancer markers, cardiac markers, Influenza, Bird flu and many more.
Viga Gemilang is a medical device company and a leader in rapid, point-of-care testing (POCT) diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and physicians’ offices. Viga Gemilang also develops information technology systems to manage point-of-care diagnostic test results using compliant software solutions.